Literature DB >> 27477292

Diabetes mellitus as a risk factor for incident chronic kidney disease and end-stage renal disease in women compared with men: a systematic review and meta-analysis.

Yanjue Shen1,2, Rongrong Cai1,2, Jie Sun1,2, Xue Dong1,2, Rong Huang1,2, Sai Tian1,2, Shaohua Wang3.   

Abstract

Diabetes mellitus is a strong risk factor for chronic kidney disease and end-stage renal disease. Whether sex differences in chronic kidney disease and end-stage renal disease incidence exist among diabetic patients remains unclear. This systematic review and meta-analysis was conducted to evaluate the relative effect of diabetes on chronic kidney disease and end-stage renal disease risk in women compared with men. We systematically searched Embase, PubMed, and the Cochrane Library for both cohort and case-control studies until October 2015. Studies were selected if they reported a sex-specific relationship between diabetes mellitus and chronic kidney disease or end-stage renal disease. We generated pooled estimates across studies using random-effects meta-analysis after log transformation with inverse variance weighting. Ten studies with data from more than 5 million participants were included. The pooled adjusted risk ratio of chronic kidney disease associated with diabetes mellitus was 3.34 (95 % CI 2.27, 4.93) in women and 2.84 (95 % CI 1.73, 4.68) in men. The data showed no difference in diabetes-related chronic kidney disease risk between the sexes (pooled adjusted women-to-men relative risk ratio was 1.14 [95 % CI 0.97, 1.34]) except for end-stage renal disease-the pooled adjusted women-to men relative risk ratio was 1.38 (95 % CI 1.22, 1.55; p = 0.114, I² = 38.1 %). The study found no evidence of a sex difference in the association between diabetes mellitus and chronic kidney disease. However, the excess risk for end-stage renal disease was higher in women with diabetes than in men with the same condition, from which we assume that the female gender could accelerate the disease progression. Further studies are needed to support this notion and elucidate the underlying mechanisms.

Entities:  

Keywords:  Chronic kidney disease; Diabetes mellitus; End-stage renal disease; Meta-analysis; Sex

Mesh:

Year:  2016        PMID: 27477292     DOI: 10.1007/s12020-016-1014-6

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  56 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

2.  Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74.

Authors:  Ravi Retnakaran; Carole A Cull; Kerensa I Thorne; Amanda I Adler; Rury R Holman
Journal:  Diabetes       Date:  2006-06       Impact factor: 9.461

3.  17beta-Estradiol supplementation reduces tubulointerstitial fibrosis by increasing MMP activity in the diabetic kidney.

Authors:  Richard W Mankhey; Corinne C Wells; Faizah Bhatti; Christine Maric
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-08-24       Impact factor: 3.619

4.  Risk factors for end-stage renal disease in a community-based population: 26-year follow-up of 25,821 men and women in eastern Finland.

Authors:  M Kastarinen; A Juutilainen; H Kastarinen; V Salomaa; P Karhapää; J Tuomilehto; C Grönhagen-Riska; P Jousilahti; P Finne
Journal:  J Intern Med       Date:  2010-11-19       Impact factor: 8.989

5.  Effect of gender on the progression of nondiabetic renal disease: a meta-analysis.

Authors:  Joel Neugarten; Anjali Acharya; Sharon R Silbiger
Journal:  J Am Soc Nephrol       Date:  2000-02       Impact factor: 10.121

6.  The effect of diabetes on incidence and mortality in end-stage renal disease in Germany.

Authors:  Falk Hoffmann; Burkhard Haastert; Michael Koch; Guido Giani; Gerd Glaeske; Andrea Icks
Journal:  Nephrol Dial Transplant       Date:  2010-10-19       Impact factor: 5.992

7.  Role of androgens in mediating renal injury in aging SHR.

Authors:  Lourdes A Fortepiani; Licy Yanes; Huimin Zhang; Lorraine C Racusen; Jane F Reckelhoff
Journal:  Hypertension       Date:  2003-10-20       Impact factor: 10.190

8.  Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland.

Authors:  Melanie K Haroun; Bernard G Jaar; Sandra C Hoffman; George W Comstock; Michael J Klag; Josef Coresh
Journal:  J Am Soc Nephrol       Date:  2003-11       Impact factor: 10.121

9.  17beta-Estradiol replacement improves renal function and pathology associated with diabetic nephropathy.

Authors:  Richard W Mankhey; Faizah Bhatti; Christine Maric
Journal:  Am J Physiol Renal Physiol       Date:  2004-09-28

10.  Risk factor, age and sex differences in chronic kidney disease prevalence in a diabetic cohort: the pathways study.

Authors:  Margaret K Yu; Courtney Rees Lyles; Luis A Bent-Shaw; Bessie A Young
Journal:  Am J Nephrol       Date:  2012-09-04       Impact factor: 3.754

View more
  40 in total

1.  Sex-Related Disparities in CKD Progression.

Authors:  Ana C Ricardo; Wei Yang; Daohang Sha; Lawrence J Appel; Jing Chen; Marie Krousel-Wood; Anjella Manoharan; Susan Steigerwalt; Jackson Wright; Mahboob Rahman; Sylvia E Rosas; Milda Saunders; Kumar Sharma; Martha L Daviglus; James P Lash
Journal:  J Am Soc Nephrol       Date:  2018-12-03       Impact factor: 10.121

2.  Therapeutic strategies for type 2 diabetes mellitus patients with very high HbA1c: is insulin the only option?

Authors:  Muhammad Abdul-Ghani; Ralph DeFronzo
Journal:  Ann Transl Med       Date:  2018-12

3.  The FDA Metformin Label Change and Racial and Sex Disparities in Metformin Prescription among Patients with CKD.

Authors:  Jung-Im Shin; Yingying Sang; Alex R Chang; Stephan C Dunning; Josef Coresh; Lesley A Inker; Elizabeth Selvin; Shoshana H Ballew; Morgan E Grams
Journal:  J Am Soc Nephrol       Date:  2020-07-13       Impact factor: 10.121

Review 4.  Second-line Glucose-Lowering Therapy in Type 2 Diabetes Mellitus.

Authors:  Jung-Im Shin
Journal:  Curr Diab Rep       Date:  2019-07-08       Impact factor: 4.810

Review 5.  Sex differences in the burden of type 2 diabetes and cardiovascular risk across the life course.

Authors:  Amy G Huebschmann; Rachel R Huxley; Wendy M Kohrt; Philip Zeitler; Judith G Regensteiner; Jane E B Reusch
Journal:  Diabetologia       Date:  2019-08-27       Impact factor: 10.122

6.  Association of diabetes with failure to achieve complete remission of idiopathic membranous nephropathy.

Authors:  Huaiya Xie; Chao Li; Yubing Wen; Wei Ye; Jianfang Cai; Hang Li; Xuemei Li; Xuewang Li
Journal:  Int Urol Nephrol       Date:  2019-12-09       Impact factor: 2.370

Review 7.  Sex-related differences in diabetic kidney disease: A review on the mechanisms and potential therapeutic implications.

Authors:  Federica Piani; Isabella Melena; Kalie L Tommerdahl; Natalie Nokoff; Robert G Nelson; Meda E Pavkov; Daniël H van Raalte; David Z Cherney; Richard J Johnson; Kristen J Nadeau; Petter Bjornstad
Journal:  J Diabetes Complications       Date:  2020-12-31       Impact factor: 2.852

8.  Sex differences in the association of prediabetes and type 2 diabetes with microvascular complications and function: The Maastricht Study.

Authors:  Rianneke de Ritter; Simone J S Sep; Carla J H van der Kallen; Marleen M J van Greevenbroek; Marit de Jong; Rimke C Vos; Michiel L Bots; Jos P H Reulen; Alfons J H M Houben; Carroll A B Webers; Tos T J M Berendschot; Pieter C Dagnelie; Simone J P M Eussen; Miranda T Schram; Annemarie Koster; Sanne A E Peters; Coen D A Stehouwer
Journal:  Cardiovasc Diabetol       Date:  2021-05-07       Impact factor: 8.949

9.  Multiple organochlorine pesticide exposures and measures of sex steroid hormones in adult males: Cross-sectional findings from the 1999-2004 National Health and Nutrition Examination Survey.

Authors:  Jessica M Madrigal; Robert M Sargis; Victoria Persky; Mary E Turyk
Journal:  Int J Hyg Environ Health       Date:  2020-09-28       Impact factor: 5.840

Review 10.  Gender Differences in Diabetic Kidney Disease: Focus on Hormonal, Genetic and Clinical Factors.

Authors:  Annalisa Giandalia; Alfio Edoardo Giuffrida; Guido Gembillo; Domenico Cucinotta; Giovanni Squadrito; Domenico Santoro; Giuseppina T Russo
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.